Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials

SIMPLE SUMMARY: Dedifferentiated chondrosarcoma is a rare type of cancer that is very aggressive and has a poor prognosis with poor survival rates. This disease can affect anyone of any age, but it is usually diagnosed among people 50 years of age or older. There is no standard treatment available;...

Descripción completa

Detalles Bibliográficos
Autores principales: Zając, Weronika, Dróżdż, Julia, Kisielewska, Weronika, Karwowska, Weronika, Dudzisz-Śledź, Monika, Zając, Agnieszka E., Borkowska, Aneta, Szumera-Ciećkiewicz, Anna, Szostakowski, Bartłomiej, Rutkowski, Piotr, Czarnecka, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417069/
https://www.ncbi.nlm.nih.gov/pubmed/37568740
http://dx.doi.org/10.3390/cancers15153924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417069/
https://www.ncbi.nlm.nih.gov/pubmed/37568740
http://dx.doi.org/10.3390/cancers15153924

Ejemplares similares